000			02171nam a22003495i 4500
001			309918
003			MX-SnUAN
005			20160429160331.0
007			cr nn 008mamaa
008			150903s2013 au | o |||| 0|eng d
020			_a9783709113318 _99783709113318
024	7		_a10.1007/9783709113318 _2doi
035			_avtls000362631
039		9	_a201509031039 _bVLOAD _c201405070333 _dVLOAD _y201402211054 _zstaff
040			_aMX-SnUAN _bspa _cMX-SnUAN _erda
050		4	_aRC627.5-632
100	1		_aBeck-Nielsen, Henning. _eeditor. _9350420
245	1	4	_aThe Metabolic Syndrome : _bPharmacology and Clinical Aspects / _cedited by Henning Beck-Nielsen.
264		1	_aVienna : _bSpringer Vienna : _bImprint: Springer, _c2013.
300			_axI, 229 páginas 33 ilustraciones, 26 ilustraciones en color. _brecurso en línea.
336			_atexto _btxt _2rdacontent
337			_acomputadora _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_aarchivo de texto _bPDF _2rda
500			_aSpringer eBooks
520			_aMetabolic syndrome is a common syndrome affecting about 20% of the adult population in Europe, and the prevalence is likely similar in other industrialised countries worldwide. It is mainly caused by the western lifestyle, which tends to produce abdominal obesity, but a genetic predisposition also plays a part. This syndrome, which is linked to leisure lifestyles and overeating/obesity, can develop into type 2 diabetes, cardiovascular disease and cancer. Therefore, proper treatment and prevention are essential. This book discusses lifestyle intervention and treatment, specifically with pharmacological compounds, in order to formulate a strategy for treating the metabolic syndrome in daily practice.
590			_aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710	2		_aSpringerLink (Servicio en línea) _9299170
776	0	8	_iEdición impresa: _z9783709113301
856	4	0	_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-7091-1331-8 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942			_c14
999			_c309918 _d309918